COVID-19 convalescent plasma Recruiting Phase 3 Trials for COVID-19 Pneumonia / Coronavirus Disease 2019 (COVID‑19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04535063Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia